Coronary vascular resistance in primary chronic autonomic failure

Clinical Autonomic Research

Volumn 16, Issue 4, 2006, Pages 293-295

  Li, Sheng Ting ^a   Eldadah, Basil A ^a   Sharabi, Yehonatan ^a   Pechnik, Sandra ^a   Goldstein, David S ^a  

^a NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

Author keywords

6 18F Fluorodopamine; 13N Ammonia; Autonomic failure; Autonomic nervous system; Coronary arteries; Myocardial blood flow; Positron emission tomography

Indexed keywords

FLUORODOPAMINE FLUORODEOXYGLUCOSE F 18; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; AUTONOMIC DYSFUNCTION; AUTONOMIC NERVOUS SYSTEM; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY VASCULAR RESISTANCE; DIAGNOSTIC IMAGING; HEART MUSCLE BLOOD FLOW; HEART MUSCLE PERFUSION; HUMAN; MEDICAL ASSESSMENT; SYMPATHETIC INNERVATION; VASOMOTOR REFLEX;

ADULT; AGED; AGED, 80 AND OVER; AUTONOMIC NERVOUS SYSTEM DISEASES; CORONARY VESSELS; DOPAMINE; FEMALE; HEART SEPTUM; HUMANS; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; SYMPATHETIC NERVOUS SYSTEM; VASCULAR RESISTANCE;

EID: 33746467057     PISSN: 09599851     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10286-006-0353-4     Document Type: Article

References (13)

1. Altman JD, Kinn J, Duncker DJ, Bache RJ (1994) Effect of inhibition of nitric oxide formation on coronary blood flow during exercise in the dog. Cardiovasc Res 28:119-124
2. Amino T, Orimo S, Takahashi A, Uchihara T, Mizusawa H (2005) Profound cardiac sympathetic denervation occurs in Parkinson disease. Brain Pathol 15:29-34
3. Brandt MA, Jones CE, Gwirtz PA (1993) Augmented coronary blood flow response to intracoronary norepinephrine after ventricular sympathectomy. Coron Artery Dis 4:101-107
4. Cannon WB (1939) A law of denervation. Am J Med Sci 198:737-750
5. Chilian WM, Harrison DG, Haws CW, Snyder WD, Marcus ML (1986) Adrenergic coronary tone during sub-maximal exercise in the dog is produced by circulating catecholamines. Evidence for adrenergic denervation supersensitivity in the myocardium but not in coronary vessels. Circ Res 58:68-82
6. Feigl EO (1983) Coronary physiology. Physiol Rev 63:1-205
7. Goldstein DS, Eisenhofer G, Dunn BB, Armando I, Lenders J, Grossman E, Holmes C, Kirk KL, Bacharach S, Adams R, Herscovitch P, Kopin IJ (1993) Positron emission tomographic imaging of cardiac sympathetic innervation using 6-[18F]fluorodopamine: initial findings in humans. J Am Coll Cardiol 22:1961-1971
8. Goldstein DS, Holmes C, Li ST, Bruce S, Metman LV, Cannon RO (2000) Cardiac sympathetic denervation in Parkinson disease. Ann Intern Med 133:338-347
9. Goldstein DS, Holmes C, Stuhlmuller JE, Lenders JWM, Kopin IJ (1997) 6-[18F]Fluorodopamine positron emission tomographic scanning in the assessment of cardiac sympathoneural function-studies in normal humans. Clin Auton Res 7:17-29
10. Hodgson JM, Cohen MD, Szentpetery S, Thames MD (1989) Effects of regional alpha- and beta-blockade on resting and hyperemic coronary blood flow in conscious, unstressed humans. Circulation 79:797-809
11. Li ST, Holmes C, Kopin IJ, Goldstein DS (2003) Aging-related changes in cardiac sympathetic function in humans, assessed by 6-18F-fluorodopamine PET scanning. J Nucl Med 44:1599-1603
12. Rundqvist B, Elam M, Bergmann-Sverrisdottir Y, Eisenhofer G, Friberg P (1997) Increased cardiac adrenergic drive precedes generalized sympathetic activation in human heart failure. Circulation 95:169-175
13. Senard JM, Valet P, Durrieu G, Berlan M, Tran MA, Montastruc JL, Rascol A, Montastruc P (1990) Adrenergic supersensitivity in parkinsonians with orthostatic hypotension. Eur J Clin Invest 20:613-619